DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Haude M, Ince H, Abizaid A. et al.
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.
Lancet 2016;
387: 31-39
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.